WHO ICTRP trial

Using influenza vaccination to understand and improve immune responses to…

ACTRN12620000830998 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12620000830998
Public title Using influenza vaccination to understand and improve immune responses to vaccination in patients with chronic obstructive pulmonary disease (COPD) and healthy older people.
Scientific title Immunogenicity of the influenza vaccination in patients with chronic obstructive pulmonary disease (COPD).
Primary sponsor Princess Alexandra Hospital
Secondary sponsors The University of Queensland
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Observational
Phase Not Applicable
Countries Australia
Conditions Chronic Obstructive Pulmonary Disease;Influenza viral disease; Chronic Obstructive Pulmonary Disease Influenza viral disease;Respiratory - Chronic obstructive pulmonary disease;Infection - Other infectious diseases
Interventions Open label, observational study of seasonal influenza vaccination in COPD patients and healthy age-matched control subjects. COPD patients will be recruited over three (3) seasonal influenza vaccine years, with each year considered a…
Registration date Aug 21, 2020
Target size 216
Secondary IDs Nil Known
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations